Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$9.58 USD
-0.08 (-0.83%)
Updated May 28, 2024 04:00 PM ET
After-Market: $9.58 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Amicus Therapeutics, Inc. [FOLD]
Reports for Purchase
Showing records 161 - 171 ( 171 total )
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
December 2011 Potential Milestones & Key Events - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
November 2011 Potential Milestones & Key Events - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology/Biopharmaceuticals/BioDefense: October 2011 Potential Milestones & Key Events - Monthly Update.
Provider: WEDBUSH SECURITIES INC.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of September 25
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology/Biopharmaceuticals/BioDefense: September 2011 Potential Milestones & Key Events - Monthly Update.
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q2:11 EPS Reported, Some Clinical Timing Adjustments, Remain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of August 7
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
August 2011 Potential Milestones & Key Events - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Revisiting Amicus, Upgrading to NEUTRAL from UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
March 2011 Potential Milestones & Key Events - Monthly Updates
Provider: WEDBUSH SECURITIES INC.